Last 12 months
Inside the activity.
0 purchase rows · 33 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 9 |
| Dec 2025 | 0 | 13 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 3, 2026 01:15 UTC |
Calkins DanielChief Financial Officer
|
SaleCommon Stock | 2,566 | $8.00 | $20,528.00 |
DisclosureSEC source: 0001104659-26-113361 · tm2626963-1_4seq1.xml · nonDerivative · entry 2 Calkins Daniel · CIK 0001951861 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 123,781 F2 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of RSUs. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 01:15 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 44,121 | $8.00 | $352,968.00 |
DisclosureSEC source: 0001104659-26-113362 · tm2626963-2_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 652,712 F2 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of RSUs. Read SEC document |
| September 30, 2026 Filed Oct 3, 2026 01:15 UTC |
Calkins DanielChief Financial Officer
|
GrantCommon Stock | 8,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-113361 · tm2626963-1_4seq1.xml · nonDerivative · entry 1 Calkins Daniel · CIK 0001951861 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 126,347 F1 · shares: The reported securities were subject to a performance restricted stock units ("RSU") award that was granted on January 21, 2026. 106,893 RSUs vested on September 30, 2026, upon the Issuer's Compensation Committee of the board of directors determining the performance criteria related to certain clinical development goals had been achieved. Read SEC document |
| September 30, 2026 Filed Oct 3, 2026 01:15 UTC |
Paterson DanDirector · President and CEO
|
GrantCommon Stock | 106,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-113362 · tm2626963-2_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 696,833 F1 · shares: The reported securities were subject to a performance restricted stock units ("RSU") award that was granted on January 21, 2026. 106,893 RSUs vested on September 30, 2026, upon the Issuer's Compensation Committee of the board of directors determining the performance criteria related to certain clinical development goals had been achieved. Read SEC document |
| September 21, 2026 Filed Sep 24, 2026 00:10 UTC |
Calkins DanielChief Financial Officer
|
SaleCommon Stock | 55 | $7.70 | $423.50 |
DisclosureSEC source: 0001104659-26-110070 · tm2626005-1_4seq1.xml · nonDerivative · entry 1 Calkins Daniel · CIK 0001951861 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,014 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. F2 · balance_after: The total number of shares beneficially owned includes 831 shares of common stock acquired pursuant to the Issuer's 2018 Employee Stock Purchase Plan. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:37 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 1,302 | $5.81 | $7,564.62 |
DisclosureSEC source: 0001104659-26-091172 · tm2622308-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 589,940 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 20:45 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 20,871 | $4.18 | $87,240.78 |
DisclosureSEC source: 0001104659-26-077333 · tm2618883-2_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 591,242 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 20:44 UTC |
Calkins DanielChief Financial Officer
|
SaleCommon Stock | 57 | $4.13 | $235.41 |
DisclosureSEC source: 0001104659-26-077332 · tm2618883-1_4seq1.xml · nonDerivative · entry 2 Calkins Daniel · CIK 0001951861 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 117,238 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 20:44 UTC |
Calkins DanielChief Financial Officer
|
SaleCommon Stock | 4,032 | $4.18 | $16,853.76 |
DisclosureSEC source: 0001104659-26-077332 · tm2618883-1_4seq1.xml · nonDerivative · entry 1 Calkins Daniel · CIK 0001951861 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 117,295 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| May 21, 2026 Filed May 26, 2026 22:23 UTC |
Tollefson Karin AnnaDirector
|
GrantCommon Stock | 36,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-066428 · tm2615478-3_4seq1.xml · nonDerivative · entry 1 Tollefson Karin Anna · CIK 0001976551 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,666 F1 · shares: RSUs granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest in twelve substantially equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2026 to April, 2027 and the last installment shall vest on the earlier of (i) the day before the 2027 Annual Meeting of Stockholders is held or (ii) May 31, 2027, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date. Read SEC document |
| May 21, 2026 Filed May 26, 2026 22:19 UTC |
ROBERTSON MICHELLEDirector
|
GrantCommon Stock | 36,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-066421 · tm2615478-7_4seq1.xml · nonDerivative · entry 1 ROBERTSON MICHELLE · CIK 0001755098 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,666 F1 · shares: RSUs granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest in twelve substantially equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2026 to April, 2027 and the last installment shall vest on the earlier of (i) the day before the 2027 Annual Meeting of Stockholders is held or (ii) May 31, 2027, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date. Read SEC document |
| May 21, 2026 Filed May 26, 2026 22:22 UTC |
Stuglik Brian MDirector
|
GrantCommon Stock | 36,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-066424 · tm2615478-1_4seq1.xml · nonDerivative · entry 1 Stuglik Brian M · CIK 0001716328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,147 F1 · shares: RSUs granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest in twelve substantially equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2026 to April, 2027 and the last installment shall vest on the earlier of (i) the day before the 2027 Annual Meeting of Stockholders is held or (ii) May 31, 2027, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date. Read SEC document |
| May 21, 2026 Filed May 26, 2026 22:12 UTC |
JOHNSON JOHNDirector
|
GrantCommon Stock | 36,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-066412 · tm2615478-4_4seq1.xml · nonDerivative · entry 1 JOHNSON JOHN · CIK 0001410781 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,666 F1 · shares: RSUs granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest in twelve substantially equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2026 to April, 2027 and the last installment shall vest on the earlier of (i) the day before the 2027 Annual Meeting of Stockholders is held or (ii) May 31, 2027, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date. Read SEC document |
| May 21, 2026 Filed May 26, 2026 22:21 UTC |
Rowinsky Eric KDirector
|
GrantCommon Stock | 36,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-066422 · tm2615478-5_4seq1.xml · nonDerivative · entry 1 Rowinsky Eric K · CIK 0001318886 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,666 F1 · shares: RSUs granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest in twelve substantially equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2026 to April, 2027 and the last installment shall vest on the earlier of (i) the day before the 2027 Annual Meeting of Stockholders is held or (ii) May 31, 2027, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date. Read SEC document |
| May 21, 2026 Filed May 26, 2026 22:18 UTC |
Kapur AnilDirector
|
GrantCommon Stock | 36,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-066418 · tm2615478-2_4seq1.xml · nonDerivative · entry 1 Kapur Anil · CIK 0001730703 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,666 F1 · shares: RSUs granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest in twelve substantially equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2026 to April, 2027 and the last installment shall vest on the earlier of (i) the day before the 2027 Annual Meeting of Stockholders is held or (ii) May 31, 2027, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date. Read SEC document |
| May 21, 2026 Filed May 26, 2026 22:12 UTC |
Bunn Paul A.Director
|
GrantCommon Stock | 36,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-066413 · tm2615478-9_4seq1.xml · nonDerivative · entry 1 Bunn Paul A. · CIK 0001868760 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,333 F1 · shares: RSUs granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest in twelve substantially equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2026 to April, 2027 and the last installment shall vest on the earlier of (i) the day before the 2027 Annual Meeting of Stockholders is held or (ii) May 31, 2027, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date. Read SEC document |
| May 21, 2026 Filed May 27, 2026 21:45 UTC |
BAILEY MICHAEL PDirector
|
GrantCommon Stock | 108,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-067048 · tm2615478-6_4seq1.xml · nonDerivative · entry 1 BAILEY MICHAEL P · CIK 0001255856 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,000 F1 · shares: 36,000 restricted stock units granted to the Reporting Person as an annual grant under the Issuer's Amended and Restated 2021 Equity Incentive Plan ("Annual Grant RSUs"). Each Annual Grant RSU represents the contingent right to receive one share of Common Stock. The Annual Grant RSUs vest in twelve substantially equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2026 to April, 2027 and the last installment shall vest on the earlier of (i) the day before the 2027 Annual Meeting of Stockholders is held or (ii) May 31, 2027, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date. F2 · shares: 72,000 restricted stock units granted to the Reporting Person as an initial grant under the Issuer's Amended and Restated 2021 Equity Incentive Plan ("Initial Grant RSUs"). Each Initial Grant RSU represents the contingent right to receive one share of Common Stock. The Initial Grant RSUs vest in twelve substantially equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest) on each quarterly anniversary of May 21, 2026 (the "Start Date") until the award is fully vested on the date that is three (3) years from the Start Date, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date. Read SEC document |
| May 04, 2026 Filed May 6, 2026 20:01 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 806 | $5.82 | $4,690.92 |
DisclosureSEC source: 0001104659-26-056226 · tm2613656-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 612,113 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| March 20, 2026 Filed Mar 23, 2026 21:20 UTC |
Calkins DanielChief Financial Officer
|
GrantCommon Stock | 57 | $5.74 | $327.18 |
DisclosureSEC source: 0001104659-26-033407 · tm269583-1_4seq1.xml · nonDerivative · entry 1 Calkins Daniel · CIK 0001951861 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,327 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| February 04, 2026 Filed Feb 5, 2026 21:10 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 970 | $6.69 | $6,489.30 |
DisclosureSEC source: 0001104659-26-010891 · tm265273-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 612,919 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| January 21, 2026 Filed Jan 23, 2026 21:58 UTC |
Calkins DanielChief Financial Officer
|
GrantCommon Stock | 16,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-006282 · tm263949-2_4seq1.xml · nonDerivative · entry 1 Calkins Daniel · CIK 0001951861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,384 F1 · shares: Restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest as to 33.3% of the RSUs on the first three anniversaries of January 21, 2026 such that the award is fully vested on January 21, 2029 (with the number of RSUs vesting on each vesting date rounded down to the nearest whole RSU, except with respect to the final vesting date on which all remaining unvested RSUs shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| January 21, 2026 Filed Jan 23, 2026 21:57 UTC |
Paterson DanDirector · President and CEO
|
GrantCommon Stock | 213,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-006279 · tm263949-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 613,889 F1 · shares: Restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest as to 33.3% of the RSUs on the first three anniversaries of January 21, 2026 such that the award is fully vested on January 21, 2029 (with the number of RSUs vesting on each vesting date rounded down to the nearest whole RSU, except with respect to the final vesting date on which all remaining unvested RSUs shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 22:12 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 10,321 | $7.16 | $73,898.36 |
DisclosureSEC source: 0001104659-26-003789 · tm263206-2_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 400,104 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 22:11 UTC |
Calkins DanielChief Financial Officer
|
SaleCommon Stock | 5,039 | $7.16 | $36,079.24 |
DisclosureSEC source: 0001104659-26-003787 · tm263206-1_4seq1.xml · nonDerivative · entry 1 Calkins Daniel · CIK 0001951861 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,719 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:01 UTC |
Kauffman MichaelDirector · President of Development
|
GrantStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $6.88 | $0.00 |
DisclosureSEC source: 0001104659-26-002117 · tm262491-1_4seq1.xml · derivative · entry 1 Kauffman Michael · CIK 0001364719 · Director · President of Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2036-01-06 F1 · derivative.exercise_date: The stock option vests 33.33% of the shares on the first anniversary of January 6, 2026 (the "Grant Date"), and an additional 8.33% will vest at the end of each successive three-month period following the first anniversary of the Grant Date until the third anniversary of the Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest) provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| December 24, 2025 Filed Dec 29, 2025 17:24 UTC |
Calkins DanielChief Financial Officer
|
SaleCommon Stock | 80 | $7.86 | $628.80 |
DisclosureSEC source: 0001104659-25-124695 · tm2534347-1_4seq1.xml · nonDerivative · entry 1 Calkins Daniel · CIK 0001951861 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,758 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 21:47 UTC |
Stuglik Brian MDirector
|
SaleCommon Stock | 592 | $9.14 | $5,410.88 |
DisclosureSEC source: 0001104659-25-122579 · tm2533899-3_4seq1.xml · nonDerivative · entry 1 Stuglik Brian M · CIK 0001716328 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,147 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 21:45 UTC |
Gagnon Robert E.Director
|
SaleCommon Stock | 283 | $9.14 | $2,586.62 |
DisclosureSEC source: 0001104659-25-122576 · tm2533899-1_4seq1.xml · nonDerivative · entry 1 Gagnon Robert E. · CIK 0001504983 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,678 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 21:46 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 393 | $9.14 | $3,592.02 |
DisclosureSEC source: 0001104659-25-122578 · tm2533899-2_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 410,425 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 22:06 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 2,000 | $10.00 | $20,000.00 |
DisclosureSEC source: 0001104659-25-120709 · tm2533371-1_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 410,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 22:06 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 2,000 | $10.07 | $20,140.00 |
DisclosureSEC source: 0001104659-25-120709 · tm2533371-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 412,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 09, 2025 Filed Dec 9, 2025 22:03 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 2,000 | $10.25 | $20,500.00 |
DisclosureSEC source: 0001104659-25-119712 · tm2533088-1_4seq1.xml · nonDerivative · entry 3 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 414,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 08, 2025 Filed Dec 9, 2025 22:03 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 2,000 | $10.50 | $21,000.00 |
DisclosureSEC source: 0001104659-25-119712 · tm2533088-1_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 416,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 22:03 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 2,000 | $10.61 | $21,220.00 |
DisclosureSEC source: 0001104659-25-119712 · tm2533088-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 418,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 04, 2025 Filed Dec 4, 2025 21:54 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 2,000 | $10.00 | $20,000.00 |
DisclosureSEC source: 0001104659-25-118490 · tm2532778-1_4seq1.xml · nonDerivative · entry 3 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 420,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 03, 2025 Filed Dec 4, 2025 21:54 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 2,000 | $10.00 | $20,000.00 |
DisclosureSEC source: 0001104659-25-118490 · tm2532778-1_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 422,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:54 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 2,000 | $10.32 | $20,640.00 |
DisclosureSEC source: 0001104659-25-118490 · tm2532778-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 424,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 01, 2025 Filed Dec 1, 2025 21:40 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 2,000 | $10.39 | $20,780.00 |
DisclosureSEC source: 0001104659-25-117345 · tm2532479-1_4seq1.xml · nonDerivative · entry 3 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 426,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 21:40 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 2,000 | $10.79 | $21,580.00 |
DisclosureSEC source: 0001104659-25-117345 · tm2532479-1_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 428,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 21:40 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 2,000 | $10.32 | $20,640.00 |
DisclosureSEC source: 0001104659-25-117345 · tm2532479-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 430,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 25, 2025 Filed Nov 25, 2025 22:32 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 2,000 | $10.00 | $20,000.00 |
DisclosureSEC source: 0001104659-25-116059 · tm2532206-1_4seq1.xml · nonDerivative · entry 3 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 432,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 24, 2025 Filed Nov 25, 2025 22:32 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 2,000 | $10.00 | $20,000.00 |
DisclosureSEC source: 0001104659-25-116059 · tm2532206-1_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 434,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 22:34 UTC |
Kauffman MichaelDirector
|
SaleCommon Stock | 8,550 | $10.00 | $85,500.00 |
DisclosureSEC source: 0001104659-25-116060 · tm2532206-3_4seq1.xml · nonDerivative · entry 1 Kauffman Michael · CIK 0001364719 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,666 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 through $10.01, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 22:35 UTC |
Bunn Paul A.Director
|
Exercise / conversionStock Options (right to buy) · Derivative | 6,250 | $0.00 Strike: $3.27 | $0.00 |
DisclosureSEC source: 0001104659-25-116061 · tm2532206-2_4seq1.xml · derivative · entry 3 Bunn Paul A. · CIK 0001868760 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 6,250 shares Expires 2034-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: The stock option vested in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion vested). The first eleven installments vested beginning on the last day of the month over the period from June, 2024 to April, 2025 and the last installment vested on the day before the 2025 Annual Meeting of Stockholders. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 22:35 UTC |
Bunn Paul A.Director
|
Exercise / conversionCommon Stock | 6,250 | $3.27 | $20,437.50 |
DisclosureSEC source: 0001104659-25-116061 · tm2532206-2_4seq1.xml · nonDerivative · entry 2 Bunn Paul A. · CIK 0001868760 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 22:35 UTC |
Bunn Paul A.Director
|
SaleCommon Stock | 6,250 | $10.00 | $62,500.00 |
DisclosureSEC source: 0001104659-25-116061 · tm2532206-2_4seq1.xml · nonDerivative · entry 1 Bunn Paul A. · CIK 0001868760 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,083 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 through $10.01, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 22:32 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 2,000 | $10.00 | $20,000.00 |
DisclosureSEC source: 0001104659-25-116059 · tm2532206-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 436,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 03, 2025 Filed Nov 6, 2025 17:21 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 2,000 | $10.00 | $20,000.00 |
DisclosureSEC source: 0001104659-25-107585 · tm2530382-1_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 438,818 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 03, 2025 Filed Nov 6, 2025 17:21 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 1,299 | $9.35 | $12,145.65 |
DisclosureSEC source: 0001104659-25-107585 · tm2530382-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 440,818 F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| October 09, 2025 Filed Oct 14, 2025 20:31 UTC |
Bunn Paul A.Director
|
SaleCommon Stock | 8,333 | $9.06 | $75,496.98 |
DisclosureSEC source: 0001104659-25-099308 · tm2528645-1_4seq1.xml · nonDerivative · entry 1 Bunn Paul A. · CIK 0001868760 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,333 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.70 through $9.33, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.